Evidence map›Paper›PMID 28500644›Full record

ArticleBritish journal of pharmacology2017

Stimulation of autophagy prevents intestinal mucosal inflammation and ameliorates murine colitis.

Dulce C Macias-Ceja, Jesús Cosín-Roger, Dolores Ortiz-Masiá, Pedro Salvador, Carlos Hernández, Juan V Esplugues, Sara Calatayud, María D Barrachina

Open access · bronzeAbstract read
In one paragraph

Article in British journal of pharmacology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 48 papers.

0numbers the graph read from it
0cells of the map it votes in
48citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

48 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. International journal of molecular sciences · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Autophagy and its role in gastrointestinal diseases.World journal of gastroenterology · 2024
    Article
  10. Pharmaceuticals (Basel, Switzerland) · 2024
    Article
  11. Journal of agricultural and food chemistry · 2024
    Article
  12. Recombinant probioticFrontiers in microbiology · 2024
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Dulce C Macias-CejaFISABIO, Hospital Dr. Peset, Valencia, Spain.
Jesús Cosín-RogerDepartamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.
Dolores Ortiz-MasiáDepartamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.
Pedro SalvadorDepartamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.
Carlos HernándezFISABIO, Hospital Dr. Peset, Valencia, Spain.ORCID 0000-0001-8536-429X
Juan V EspluguesFISABIO, Hospital Dr. Peset, Valencia, Spain.
Sara CalatayudDepartamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0001-9675-2423
María D BarrachinaDepartamento de Farmacología and CIBERehd, Facultad de Medicina, Universidad de Valencia, Valencia, Spain.ORCID 0000-0002-4332-2929
Universitat de València · ESFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeDefective autophagy contributes to the pathogenesis of inflammatory disorders such as inflammatory bowel disease and there are interactions between autophagy and inflammation. Here we have analysed the effects of autophagy stimulators on murine colitis. EXPERIMENTAL APPROACH: Mice were treated with intrarectal administration of 2,4,6-trinitrobenzenesulfonic acid (TNBS) (3.5 mg·20 g KEY

resultsImpaired autophagy associated with body weight loss and intestinal damage was detected in the mucosa of TNBS-treated mice. Administration of trehalose, rapamycin or betanin prevented the impaired autophagic flux induced by TNBS and decreased mucosal protein levels of BCL10, p-IκBα and NFκB-p65 and the expression of pro-inflammatory cytokines and M1 macrophage markers. Blockade of autophagosome formation by treatment with 3MA, prevented the reduction in protein levels of p62, BCL10, p-IκBα and NFκB-p65 induced by betanin in TNBS-treated mice and weakened the protective effects of betanin on murine colitis. CONCLUSIONS AND IMPLICATIONS: Pharmacological stimulation of mucosal autophagy reduced intestinal inflammation and improved murine colitis.

Indexed as

Administration, RectalAnimalsAutophagyBetacyaninsColitisFemaleInflammationInjections, IntraperitonealIntestinal MucosaMaleMiceMice, Inbred BALB CSirolimusTrehaloseTrinitrobenzenesulfonic AcidBetacyaninsbetaninSirolimusTrehaloseTrinitrobenzenesulfonic Acid

Identifiers

PMID28500644
PMCPMC5513861
OpenAlexW2612662007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.